Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 499 entries
View as:

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Phase: N/A Priority: Normal
NCT ID: NCT00869206 Org: User:
Start: 03/31/09 End: 01/31/17 Due: 01/31/18

Biomarkers in Native American Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00898976 Org: User:
Start: 08/31/98 End: 05/31/07 Due: 05/31/08

Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01336894 Org: User:
Start: 05/31/11 End: 03/27/17 Due: 03/27/18

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00553501 Org: User:
Start: 03/31/08 End: 07/31/14 Due: 07/31/15

Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00107172 Org: User:
Start: 07/31/05 End: 02/15/19 Due: 02/15/20

Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00032006 Org: User:
Start: 02/28/02 End: 10/31/03 Due: 10/31/04

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

Phase: N/A Priority: Normal
NCT ID: NCT01562288 Org: User:
Start: 02/29/12 End: 04/30/19 Due: 04/30/20

Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006359 Org: User:
Start: 09/30/00 End: 03/31/12 Due: 03/31/13

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00006747 Org: User:
Start: 11/30/00 End: 02/28/03 Due: 02/28/04

Genetic Study in Patients With Stage II or Stage III Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003833 Org: User:
Start: 02/28/99 End: 08/31/06 Due: 08/31/07

Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00662129 Org: User:
Start: 11/30/08 End: 08/31/13 Due: 08/31/14

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00079001 Org: User:
Start: 01/31/04 End: 10/31/14 Due: 10/31/15

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04803201 Org: User:
Start: 10/08/21 End: 06/30/26 Due: 06/30/27

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Phase: N/A Priority: Normal
NCT ID: NCT05751668 Org: User:
Start: 11/02/23 End: 05/31/30 Due: 05/31/31

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00054418 Org: User:
Start: 03/31/03 End: 05/31/08 Due: 05/31/09

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00033592 Org: User:
Start: 02/28/02 End: 07/31/06 Due: 07/31/07

Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00362986 Org: User:
Start: 10/31/06 End: 10/31/09 Due: 10/31/10

High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003623 Org: User:
Start: 10/31/99 End: 03/31/03 Due: 03/31/04

Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00058357 Org: User:
Start: 05/31/04 End: 07/31/07 Due: 07/31/08

Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00550836 Org: User:
Start: 03/31/09 End: 05/31/13 Due: 05/31/14

Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00014534 Org: User:
Start: 03/31/04 End: 04/30/09 Due: 04/30/10

Paclitaxel in Treating Older Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003092 Org: User:
Start: 09/30/97 End: 06/30/06 Due: 06/30/07

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00005810 Org: User:
Start: 03/31/00 End: 06/30/06 Due: 06/30/07

Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy

Phase: N/A Priority: Normal
NCT ID: NCT04989504 Org: User:
Start: 07/26/22 End: 02/15/29 Due: 02/15/30

Irinotecan in Treating Aging Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00026195 Org: User:
Start: 09/30/01 End: 06/30/06 Due: 06/30/07